IL24 and colorectal carcinoma: VG9-IL-24 induced specific and durable immune responses against colorectal tumors, produced enhanced killing of CRC cells, and inhibited the growth of colorectal cancer tumors, including through the induction of apoptosis in CRC cells via multiple apoptotic signaling pathways.